Business Development 2001-2010

Total revenues by division

7,721

7,521

7,364

6,017

5,887

6,310

7,081

7,590

7,747

9,291

19.9

Pharmaceuticals

3,484

3,265

3,458

3,601

3,905

4,163

4,900

5,456

5,812

6,226

7.1

Merck Serono

2,228

1,850

1,546

1,619

1,817

1,938

4,480

5,014

5,345

5,754

7.6

Generics²

936

1,096

1,585

1,625

1,712

1,825

–

–

–

–

–

Consumer Health Care

320

319

327

357

376

400

420

442

467

472

1.1

Chemicals

1,729

1,791

1,707

1,696

1,906

2,113

2,152

2,127

1,935

3,065

58.4

Merck Millipore

–

–

–

–

–

–

–

–

929¹

1,681

80.9

Performance Materials

–

–

–

–

–

–

–

–

1,006¹

1,384

37.7

Liquid Crystals

297

383

443

589

741

895

916

878

–

–

–

Performance & Life Science Chemicals

1,216

1,216

1,083

1,107

1,165

1,218

1,236

1,249

–

–

–

Electronic Chemicals²

216

192

181

–

–

–

–

–

–

–

–

Laboratory Distribution²

2,754

2,711

2,427

582

–

–

–

–

–

–

–

Intragroup sales, Laboratory

–246

–246

–228

–62

–

–

–

–

–

–

–

Corporate and Other

–

–

–

200

76

34

29

7

–

–

–

Operating result by business sector

877

616

736

776

883

1,105

976

1,131

649

1,113

71.6

Pharmaceuticals

581

272

389

391

454

524

417

655

403

579

43.7

Chemicals

204

260

316

420

492

641

631

558

324

624

92.4

Laboratory Distribution²

92

84

79

21

–

–

–

–

–

–

–

Corporate and Other

–

–

–48

–56

–63

–60

–72

–81

–78

–90

14.1

Earnings before income and taxes (EBIT)

1,286

559

538

1,044

956

1,325

200

731

621

1,113

79.2

EBIT before depreciation and amortization (EBITDA)

1,694

985

1,008

1,419

1,245

1,628

1,858

1,947

1,625

2,457

51.2

Profit before tax

1,078

412

423

961

893

1,273

–111

575

486

861

77.0

Profit after tax

655

215

218

672

673

1,001

3,520³

379

377

642

70.3

Free cash flow

664

441

442

1,889

657

–1,073

–1,473³

438

812

–3,522

–

Capital expenditure on property, plant and equipment

470

377

281

234

268

253

283³

395

467

396

–15.2

Research and development

577

608

605

599

713

752

1,028

1,234

1,345

1,397

3.9

Total assets

8,255

7,511

6,982

5,754

7,281

8,102

14,922

15,645

16,713

22,388

34.0

Net equity

2,336

2,054

2,363

2,800

3,329

3,807

8,688

9,563

9,514

10,372

9.0

Employees (number as of December 31)

34,294

34,504

34,206

28,877

29,133

29,999

30,968

32,800

33,062

40,562

22.7

Return on sales in % (ROS: Operating result/total revenues)

11.4

8.2

10.0

12.9

15.0

17.5

13.8

14.9

8.4

12.0

Earnings per share in EUR

3.66

1.18

1.15

3.47

3.40

5.07

16.21³

1.69

1.68

2.91

73.2

Dividend per share in EUR

0.95

1.00

0.80

0.80

0.85

0.90

1.20

1.50

1.00

1.25

25.0

One-time bonus per share in EUR

–

–

–

0.20

–

0.15

2.00

–

–

–

–